Prévalence de la maladie rénale chronique en France, Esteban 2014–2016
Valérie Olié(l'Assurance Maladie), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), A. Gabet(Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail), Lynda Cheddani(Hôtel-Dieu de Paris), Jacques Blacher(Université Paris Cité), Clémence Grave(Santé Publique France), Bénédicte Stengel(Inserm)
Cited by 18
Related Papers
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure
|JAMA|2016|696
CKD Prevalence Varies across the European General Population
|Journal of the American Society of Nephrology|2015|588
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
|The Lancet|2012|444
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
|The Lancet Diabetes & Endocrinology|2019|330